The state of clinical trials has been impacted by the COVID-19 pandemic. In December’s Facebook Live event, experts highlighted the integral role of the navigator in providing assessment, education, and support for patients with cancer who are considering their clinical trial options.
Dr Michael Roth stresses the importance of understanding the interaction of providers, researchers, and navigators to more effectively improve AYA clinical trial enrollment.
Dr. Michael Roth believes that enhanced clinical trial enrollment will improve survival and quality of life for AYAs, and stresses the need to determine and overcome barriers to AYA clinical trial enrollment.
Dr Michael Roth states that clinical trials are less accessible to adolescents and young adults than other populations for a variety of reasons. Watch the video to learn more.
Dr Michael Roth notes that clinical trial enrollment for adolescents and young adults is much lower than for younger patients and cites a need for greater understanding of barriers to enrollment.